scholarly journals Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
Wei Guo ◽  
Xiao Ma ◽  
Christine Xue ◽  
Jianfeng Luo ◽  
Xiaoli Zhu ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Tumor Marker ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Univariate Analysis ◽  
Rank Test ◽  
Healthy Controls ◽  
The Mean

Background. Recent studies have revealed that clusterin is implicated in many physiological and pathological processes, including tumorigenesis. However, the relationship between serum clusterin expression and esophageal squamous cell carcinoma (ESCC) is unclear.Methods. The serum clusterin concentrations of 87 ESCC patients and 136 healthy individuals were examined. An independent-samples Mann-WhitneyUtest was used to compare serum clusterin concentrations of ESCC patients to those of healthy controls. Univariate analysis was conducted using the log-rank test and multivariate analyses were performed using the Cox proportional hazards model.Results. In healthy controls, the mean clusterin concentration was288.8±75.1 μg/mL, while in the ESCC patients, the mean clusterin concentration was higher at412.3±159.4 μg/mL (P<0.0001). The 1-, 2-, and 4-year survival rates for the 87 ESCC patients were 89.70%, 80.00%, and 54.50%. Serum clusterin had an optimal diagnostic cut-off point (serum clusterin concentration = 335.5 μg/mL) for esophageal squamous cell carcinoma with sensitivity of 71.26% and specificity of 77.94%. And higher serum clusterin concentration (>500 μg/mL) indicated better prognosis (P=0.030).Conclusions. Clusterin may play a key role during tumorigenesis and tumor progression of ESCC and it could be applied in clinical work as a tumor marker and prognostic factor.

scholarly journals Mina53 as a Potential Prognostic Factor for Esophageal Squamous Cell Carcinoma

2004 ◽  
Vol 10 (21) ◽  
pp. 7347-7356 ◽  
Author(s):  
Makoto Tsuneoka ◽  
Hiromasa Fujita ◽  
Nobuyuki Arima ◽  
Kwesi Teye ◽  
Torahiko Okamura ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Potential Prognostic Factor

scholarly journals Outcomes and Prognostic Factors of Salvage Radiation for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma

2021 ◽  
Vol 11 ◽  
Author(s):  
Chi Zhang ◽  
Xiao-Lin Ge ◽  
Chen-Jun Huang ◽  
Shu Zhang ◽  
Xin-Chen Sun
Keyword(s):  
Squamous Cell Carcinoma ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Univariate Analysis ◽  
Progression Free Survival ◽  
Combined Chemotherapy ◽  
Regional Lymph Nodes ◽  
Term Survival ◽  
Salvage Resection

Purpose: Recurrence of esophageal squamous cell carcinoma (ESCC) in regional lymph nodes (LNs) after surgical section can be treated with salvage resection, radiotherapy (RT) or chemoradiotherapy (CRT). RT or CRT is more widely used in clinic. This paper investigates the effects, toxicities and prognostic risk factors of salvage RT or CRT on patients with LN recurrence.Methods: We retrospectively analyzed the clinical outcomes of 103 patients receiving salvage RT or CRT for LN recurrence after ESCC resection. In total, 39 patients received RT alone and 64 received concurrent CRT. All the patients received intensity modulated radiation therapy (IMRT), administered with a median dose of 62 Gy (range, 50–70 Gy).Results: The median follow-up time was 44.5 months, and median survival was 22.5 months (5.5–99.5 months). One-, 3-, and 5-year overall survival (OS) were 80.6, 37.0, and 25.8%, respectively. One- and 2-year progression free survival (PFS) were 57.3 and 34.0%, respectively. Grade 3 or above toxicity was low (16.5%) and no treatment-related deaths occurred. In univariate analysis of OS, pN0 (p = 0.039), smaller LN volume (≤25 cm3, p = 0.019), combined chemotherapy (p = 0.041) and single LN recurrence (p = 0.001) were associated with prolonged OS. And pT1-2 (p = 0.044), pN0 (p = 0.042), irradiation dose (&gt;60 Gy, p = 0.044), combined chemotherapy (p = 0.019) and single LN recurrence (p = 0.002) were associated with prolonged PFS. In multivariate analysis, the patients with only one recurrent node had a significant better OS (HR = 0.556, 95% CI 0.324–0.956, p = 0.034) and PFS (HR = 0.528, 95% CI 0.339–0.847, p = 0.008).Conclusions: Salvage RT or CRT for regional LN recurrence is effective and acceptable. Fewer recurrent nodes may indicate a better long-term survival.

scholarly journals The preoperative HALP score (hemoglobin, albumin, lymphocyte and platelet) is a useful predictor in patients with resectable esophageal squamous cell carcinoma

2021 ◽  
Author(s):  
Ji-Feng Feng ◽  
Liang Wang ◽  
Xun Yang
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Roc Curve ◽  
Curative Resection ◽  
Cox Regression ◽  
Prognostic Score ◽  
Cancer Specific Survival

The hemoglobin, albumin, lymphocyte, and platelet (HALP) score has been confirmed as a prognostic factor in several types of cancers. The current study aimed to assess the prognostic value of preoperative HALP score, an inflammatory and nutritional based score, in predicting cancer-specific survival (CSS) in resectable patients undergoing curative resection for esophageal squamous cell carcinoma (ESCC). The clinical data of 355 consecutive patients with ESCC who underwent curative resection were retrospectively conducted and analyzed. The receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value for preoperative HALP. The areas under the curve (AUC) for preoperative HALP and other variables were calculated and compared. Cox regression analyses and Kaplan-Meier methods were used to identify the factors associated with CSS. According to the ROC curve, the optimal cut-off value for preoperative HALP was 31.8. The 5-year CSS for preoperative HALP low (≤31.8) and high (>31.8) was 15.1% and 47.5%, respectively (p<0.001). Preoperative HALP had reliable abilities to predict CSS in resectable ESCC patients in any stage or gender, according to the subgroup analysis based on the patients' cancer stage and gender. Multivariate analyses confirmed that preoperative HALP was an independent prognostic score regarding CSS in patients with resectable ESCC (p<0.001). This study confirmed that the preoperative HALP score could be regarded as a potential independent prognostic factor for CSS in patients with resectable ESCC.

PS02.085: ASSESSMENT OF TUMOR REGRESSION OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY: COMPARISON OF 3 COMMONLY USED SCORING APPROACHES

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 144-145
Author(s):  
Yin-Kai Chao ◽  
Hsin-Yueh Fang
Keyword(s):  
Squamous Cell Carcinoma ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Interobserver Agreement ◽  
Tumor Regression ◽  
Univariate Analysis ◽  
Neoadjuvant Chemoradiotherapy ◽  
Margin Status ◽  
Tier System

Abstract Background Tumor regression grade (TRG) is a measure of histopathological response of cancer to neoadjuvant chemoradiotherapy(nCRT) and is associated with outcomes. Several TRG system are used in esophageal cancer: Schneider 4 tier(0%,1∼10%,10∼50%, > 50% vital residual tumor cell[VRTC]), Chirieac 3 tier(0%,1∼50%, > 50% VRTC) and Japanese 4 tier(0%,1∼33%,33∼66%, > 66% VRTC). Although these methods are generally accepted, currently there is no common standard. Methods We compared the application of three major systems for assessment of tumor regression. Hematoxylin and eosin–stained slides from 370 resection specimens of esophageal squamous cell carcinoma following nCRT were independently reviewed by two pathologists. Primary endpoints included (1) interobserver agreement (2) prognostic discrimination Results Interobserver agreement was excellent for all three sutem while the Chirieac 3 tier system showed the best kappa value(0.93). All models had similar discriminatory and stratification power, and they predicted survival (P < 0.0001) on univariate analysis. While Chirieac system remained a significant predictor for overall survival independent of yp-stage and margin status in multivariate analysis. Conclusion A simple 3-tiered system with the estimation of VRTC(0%,1∼50%, > 50%) is most reproducible for the evaluation of histological response and together with yp-stage and margin status as independent predictors for survival. Disclosure All authors have declared no conflicts of interest.

scholarly journals YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

2019 ◽  
Vol 9 (5) ◽  
pp. 1628-1637
Author(s):  
Honghai Dai ◽  
Yang W. Shao ◽  
Xiaoling Tong ◽  
Xue Wu ◽  
Jiaohui Pang ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Definitive Chemoradiotherapy

Number of negative lymph nodes as a prognostic factor in esophageal squamous cell carcinoma

2016 ◽  
Vol 13 (5) ◽  
pp. e278-e283 ◽  
Author(s):  
Mingquan Ma ◽  
Peng Tang ◽  
Hongjing Jiang ◽  
Lei Gong ◽  
Xiaofeng Duan ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Lymph Nodes ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Negative Lymph Nodes

α-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma

2007 ◽  
Vol 95 (2) ◽  
pp. 148-155 ◽  
Author(s):  
Tetsuro Setoyama ◽  
Shoji Natsugoe ◽  
Hiroshi Okumura ◽  
Masataka Matsumoto ◽  
Yasuto Uchikado ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Significant Prognostic Factor ◽  
E Cadherin
Sign in / Sign up

Export Citation Format

Share Document